GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal ...
The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.
The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the ...
The proposed deal, the largest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback